一个非正规的Frizzled2通路调节了上皮细胞-介质细胞过渡和转移
Taranjit S Gujral1, Marina Chan1, Leonid Peshkin1
1Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Warren Alpert 524, Boston, MA 02115, USA.
Cell
|November 24, 2014
概括
在转移性癌症中,Frizzled2 (Fzd2) 和Wnt5a/b的含量升高,导致上皮-介质细胞过渡 (EMT) 和细胞迁移. 向Fzd2显示有望抑制瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 发育生物学 发展生物学
背景情况:
- Wnt信号对于胚胎发育至关重要.
- Wnt信号的异常与结直肠癌有关.
- 目前正在研究特定Wnt途径组件在转移中的作用.
研究的目的:
- 研究Frizzled2 (Fzd2) 和Wnt5a/b在癌症转移中的作用.
- 阐明Fzd2影响表皮层-介质细胞转换 (EMT) 和细胞迁移的分子机制.
- 在临床前癌症模型中评估针对Fzd2的治疗潜力.
主要方法:
- 在癌细胞系和瘤中分析Fzd2和Wnt5a/b的表达.
- 药理和基因操纵来研究Fzd2的功能.
- 评估EMT标记物,细胞迁移和入侵.
- 在异种移植模型中开发和测试抗Fzd2抗体.
- 基因表达造型,以识别预测性特征.
主要成果:
- 在转移性癌细胞系和高度瘤中,Fzd2和Wnt5a/b被上调调节.
- Fzd2表达与EMT标记器相关联.
- 通过非正规的Fyn/Stat3通路,Fzd2促进EMT和细胞迁移.
- 一个Fzd2调节的基因特征预测患者的转移和生存.
- 一个抗Fzd2抗体抑制了瘤生长,转移,迁移和入侵体内.
结论:
- Fzd2和Wnt5a/b在驱动癌症转移方面发挥着重要作用.
- Fzd2/Fyn/Stat3通路代表了EMT和细胞迁移的新机制.
- 用抗体准Fzd2为转移性癌症提供了一个潜在的治疗策略.
- 这一途径可能有利于患有高Fzd2和Wnt5a/b表达瘤的患者.
相关概念视频
Non-Canonical Wnt Signaling Pathways
8.6K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K
Non-Canonical Wnt Signaling Pathways
1.9K
1.9K
Canonical Wnt Signaling Pathway
11.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
11.0K
Canonical Wnt Signaling Pathway
2.7K
2.7K
Metastasis
7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
mTOR Signaling and Cancer Progression
5.2K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.2K


